Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Scandinavian Journal of Immunology
|
April 1, 1996
Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes
B R Yacyshyn, M B Bowen-Yacyshyn, L M Pilarski
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 25, 2000
Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat
Q Chang, B D Soper, B R Yacyshyn, et al.
Clinical and Experimental Immunology
|
June 17, 2005
Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1
B R Yacyshyn, A Schievella, K L Sewell, et al.
Molecular Biotechnology
|
November 11, 1999
Preclinical and clinical pharmacology of antisense oligonucleotides
E G Marcusson, B R Yacyshyn, W R Shanahan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model
Mary Beth Bowen-Yacyshyn, C F Bennett, N Nation, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1991
Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression
L M Pilarski, B R Yacyshyn, G S Jensen, et al.
The Journal of Rheumatology
|
January 26, 1999
Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives
J H Vaile, J B Meddings, B R Yacyshyn, et al.
American Journal of Hematology
|
May 1, 1993
Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma
G S Jensen, A R Belch, M J Mant, et al.
Alimentary Pharmacology & Therapeutics
|
September 25, 2002
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease
B R Yacyshyn, C Barish, J Goff, et al.
Gastroenterology
|
June 3, 1998
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
B R Yacyshyn, M B Bowen-Yacyshyn, L Jewell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Scandinavian Journal of Immunology
|
April 1, 1996
Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes
B R Yacyshyn, M B Bowen-Yacyshyn, L M Pilarski
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 25, 2000
Alterations in protein kinase C isoforms in experimentally-induced colitis in the rat
Q Chang, B D Soper, B R Yacyshyn, et al.
Clinical and Experimental Immunology
|
June 17, 2005
Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1
B R Yacyshyn, A Schievella, K L Sewell, et al.
Molecular Biotechnology
|
November 11, 1999
Preclinical and clinical pharmacology of antisense oligonucleotides
E G Marcusson, B R Yacyshyn, W R Shanahan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model
Mary Beth Bowen-Yacyshyn, C F Bennett, N Nation, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1991
Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression
L M Pilarski, B R Yacyshyn, G S Jensen, et al.
The Journal of Rheumatology
|
January 26, 1999
Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives
J H Vaile, J B Meddings, B R Yacyshyn, et al.
American Journal of Hematology
|
May 1, 1993
Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma
G S Jensen, A R Belch, M J Mant, et al.
Alimentary Pharmacology & Therapeutics
|
September 25, 2002
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease
B R Yacyshyn, C Barish, J Goff, et al.
Gastroenterology
|
June 3, 1998
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
B R Yacyshyn, M B Bowen-Yacyshyn, L Jewell, et al.
Page
of 3